{"pmid": "12581572", "sentences": {"sent_1": {"Section": "", "text": "PATIENTS AND METHODS : Patients had stage IIIB ( pleural effusion ) / IV non-small cell lung cancer , measurable disease , performance status 0 - 2Eastern Cooperative Oncology Group , adequate organ function , and no prior chemotherapy .", "entities": {"entity_1": {"text": "stage IIIB ( pleural effusion ) / IV non-small cell lung cancer", "class": "Participant", "negation": 0, "UMLS": "C0149925:small cell lung cancer,C0032227:pleural effusion,C1300072:stage,", "index": 1, "start": 6}, "entity_2": {"text": "adequate organ function", "class": "Outcome", "negation": 0, "UMLS": "C0031843:function,C0178784:organ,", "index": 2, "start": 31}, "entity_3": {"text": "prior chemotherapy", "class": "Participant", "negation": 0, "UMLS": "C0392920:chemotherapy,", "index": 3, "start": 37}}, "relations": {}}, "sent_2": {"Section": "", "text": "Patients received dexamethasone premedication followed by paclitaxel at a dose of 90 mg/m ( 2 ) on days 1 , 8 , and 15 along with bryostatin - 1 50 microg/m ( 2 ) on days 2 , 9 , and 16 every 28 days until disease progression .", "entities": {"entity_4": {"text": "dexamethasone", "class": "Intervention", "negation": 0, "UMLS": "C0011777:dexamethasone,", "index": 1, "start": 2}, "entity_5": {"text": "paclitaxel", "class": "Intervention", "negation": 0, "UMLS": "C0144576:paclitaxel,", "index": 2, "start": 6}, "entity_6": {"text": "bryostatin", "class": "Intervention", "negation": 0, "UMLS": "C0054173:bryostatin,", "index": 3, "start": 26}, "entity_7": {"text": "disease progression", "class": "Outcome", "negation": 0, "UMLS": "C0242656:disease progression,", "index": 4, "start": 46}}, "relations": {}}, "sent_3": {"Section": "", "text": "Correlative assays measuring serum levels of tumor necrosis factor alpha ( TNF - alpha ) , interleukin - 6 ( IL - 6 ) , and T-lymphocyte numbers were performed based on a previous study showing cytokine induction in vivo by bryostatin - 1 .", "entities": {"entity_8": {"text": "serum levels of tumor necrosis factor alpha", "class": "Outcome", "negation": 0, "UMLS": "C0333516:tumor necrosis,C0229671:serum,C0439095:alpha,", "index": 1, "start": 3}, "entity_9": {"text": "interleukin", "class": "Outcome", "negation": 0, "UMLS": "C1522405:interleukin-2,", "index": 2, "start": 16}, "entity_10": {"text": "T-lymphocyte numbers", "class": "Outcome", "negation": 0, "UMLS": "C0200635:lymphocyte number,", "index": 3, "start": 26}, "entity_11": {"text": "cytokine induction", "class": "Outcome", "negation": 0, "UMLS": "C0857127:induction,", "index": 4, "start": 36}}, "relations": {}}}}